Pitt Pediatrics congratulates Silva Arslanian, MD for co-authoring the 2024 Paul Dudley White International Scholar award winning abstract titled, “Randomized Placebo-controlled Trial of Pitavastatin Calcium To Treat Combined Dyslipidemia Of Obesity In Adolescents - The Pediatric Heart Network Dyslipidemia Of Obesity Intervention In Teens (DO IT!) Trial.” Arslanian is the Richard L. Day Professor of Pediatrics and Clinical and Translational Science in the Division of Endocrinology, as well as the Director of the Pediatric Clinical and Translational Research Center (PCTRC) and the Scientific Director of the Center for Pediatric Research in Obesity and Metabolism (CPROM). 
The DO IT! Trial is a multi-center collaborative study investigating whether or not a cholesterol-lowering drug called pitavastatin is safe and effective in children and teens who are obese with high cholesterol. Participants in this study were between the ages of 10 and 19 and completed the research period over 24 months.
Paul Dudley White was one of the founders of the American Heart Association (AHA) and a pioneer in heart health and preventative cardiology. This award in his honor has promoted his vision for excellence in cardiovascular and brain health science since 2017. Yearly awards are presented to teams of authors with the highest-ranked scientific abstract from each participating country for each AHA scientific meeting.
Help us in celebrating Arslanian and the DO IT! research team for their incredible work. Follow Pitt Pediatrics on Twitter and Instagram for more updates on faculty wins, awards, and publications.